Cryoport Operating Income Over Time
| CYRX Stock | USD 9.62 0.11 1.16% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cryoport Performance and Cryoport Correlation. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cryoport. Projected growth potential of Cryoport fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cryoport assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.22) | Revenue Per Share | Quarterly Revenue Growth 0.154 | Return On Assets | Return On Equity |
Understanding Cryoport requires distinguishing between market price and book value, where the latter reflects Cryoport's accounting equity. The concept of intrinsic value—what Cryoport's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Cryoport's price substantially above or below its fundamental value.
It's important to distinguish between Cryoport's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cryoport should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cryoport's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare Cryoport and related stocks such as Forward Air, AIRO Group Holdings, and Compass Diversified Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FWRD | 4.3 M | 77.1 M | 83.5 M | 84.4 M | 96.4 M | 81.8 M | 60 M | 108.7 M | 122 M | 112.4 M | 73.9 M | 147 M | 247.6 M | 88.2 M | (1.1 B) | (956.6 M) | (908.8 M) |
| AIRO | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (877.4 K) | (2.6 M) | (27 M) | (9.9 M) | (17.4 M) | (15.7 M) | (16.5 M) |
| CODI | 10.5 M | (8.8 M) | 53.8 M | 104.8 M | 31.9 M | 49.9 M | 19.1 M | 24.5 M | 56.6 M | 26 M | 78 M | 123.1 M | 44.4 M | (69.4 M) | (14.9 M) | (17.1 M) | (16.2 M) |
| EVTL | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (7.4 M) | (11.5 M) | (277.2 M) | (98.1 M) | (101.9 M) | (61.2 M) | (55.1 M) | (57.8 M) |
| MTRX | 1.5 M | 31.6 M | 36.7 M | 58.6 M | 8.8 M | 40.9 M | 4.9 M | (10.5 M) | 37.8 M | (36.6 M) | (43.7 M) | (87.9 M) | (52.9 M) | (30.1 M) | (35.1 M) | (31.6 M) | (30 M) |
| SRTA | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (10.4 M) | (24.1 M) | (53.5 M) | (68.1 M) | (33.9 M) | (30.5 M) | (32.1 M) |
| ZIP | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | (6.3 M) | 64.4 M | (8.4 M) | 97.2 M | 79.4 M | 1.3 M | 1.5 M | 1.4 M |
| KFRC | 800 K | 44.6 M | (54.5 M) | 21.3 M | 49.3 M | 73.9 M | 58.6 M | 68.6 M | 81.7 M | 74.8 M | 80.3 M | 106.6 M | 116.9 M | 87.1 M | 69.7 M | 80.2 M | 84.2 M |
| EBF | 19.9 M | 40.4 M | 40.4 M | 33.2 M | 54.5 M | 40.5 M | 40.5 M | 47.3 M | 50.1 M | 35.9 M | 35.9 M | 43.6 M | 66.2 M | 52 M | 52 M | 56.5 M | 42.6 M |
| BYRN | (188.7 K) | (1.9 M) | (1.7 M) | (2.7 M) | (2.1 M) | (1.7 M) | (1.9 M) | (2 M) | (3.3 M) | (4.3 M) | (3.3 M) | (7.7 M) | (7.8 M) | 6.7 M | 6.7 M | 6 M | 6.3 M |
Cryoport and related stocks such as Forward Air, AIRO Group Holdings, and Compass Diversified Operating Income description
Operating Income is the amount of profit realized from Cryoport operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cryoport is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Cryoport | CYRX |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 112 Westwood Place, |
| Exchange | NASDAQ Exchange |
USD 9.62
Additional Tools for Cryoport Stock Analysis
When running Cryoport's price analysis, check to measure Cryoport's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cryoport is operating at the current time. Most of Cryoport's value examination focuses on studying past and present price action to predict the probability of Cryoport's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cryoport's price. Additionally, you may evaluate how the addition of Cryoport to your portfolios can decrease your overall portfolio volatility.